KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16 | -99.9% | 15,019 | +22.9% | 0.00% | – |
| Q3 2022 | $11,000 | -50.0% | 12,219 | -46.0% | 0.00% | -100.0% |
| Q2 2022 | $22,000 | -77.1% | 22,619 | -69.5% | 0.00% | -80.0% |
| Q1 2022 | $96,000 | +220.0% | 74,100 | +3121.7% | 0.01% | +150.0% |
| Q1 2020 | $30,000 | 0.0% | 2,300 | +43.8% | 0.00% | 0.0% |
| Q4 2019 | $30,000 | +57.9% | 1,600 | -84.8% | 0.00% | +100.0% |
| Q3 2017 | $19,000 | -60.4% | 10,517 | -53.5% | 0.00% | 0.0% |
| Q2 2017 | $48,000 | -64.4% | 22,600 | -15.5% | 0.00% | -83.3% |
| Q1 2017 | $135,000 | +938.5% | 26,757 | +375.3% | 0.01% | – |
| Q4 2016 | $13,000 | -23.5% | 5,630 | -57.0% | 0.00% | -100.0% |
| Q3 2016 | $17,000 | +41.7% | 13,100 | +50.6% | 0.00% | – |
| Q2 2016 | $12,000 | 0.0% | 8,700 | +6.6% | 0.00% | – |
| Q1 2016 | $12,000 | -85.2% | 8,162 | -75.6% | 0.00% | -100.0% |
| Q4 2015 | $81,000 | – | 33,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |